1 Departamento de Fisioterapia, Instituto de Ciências da Saúde, Curso de Fisioterapia, Universidade Federal da Bahia (UFBA), Salvador, Brazil.
2 Physiotherapy Research Group, Universidade Federal da Bahia (UFBA), Salvador, Brazil.
Clin Rehabil. 2019 Mar;33(3):381-394. doi: 10.1177/0269215518815220. Epub 2018 Nov 28.
OBJECTIVE:: To investigate whether isokinetic muscle strengthening improves muscle strength, mobility, and gait in post-stroke patients. METHODS:: We searched for randomized controlled trials at PubMed/Medline, SciELO, PEDro, and Cochrane Central Register of Controlled Trials, from the earliest date available to June 2018. Randomized controlled trials that examined the effects of isokinetic muscle strengthening versus other rehabilitation interventions or control in post-stroke patients were included. Study quality was evaluated using the PEDro scale. Weighted mean difference (WMD) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I test. RESULTS:: In total, 13 studies (347 patients) focusing on the use of isokinetic in rehabilitation following stroke were included. All trials were of low-to-moderate quality. Isokinetic muscle strengthening improved muscle strength WMD 0.8 (95% CI: 0.2, 1.4; N = 96), mobility WMD -2.03 seconds (95% CI: -2.9, -1.1; N = 111) and gait speed WMD 0.9 m/s (95% CI: 0.05, 1.8; N = 87). CONCLUSION:: Isokinetic muscle strengthening seems to be a useful strategy for improving muscle strength, mobility, and gait in post-stroke patients.
目的:探讨等速肌肉强化是否能改善脑卒中患者的肌肉力量、活动能力和步态。
方法:我们在 PubMed/Medline、SciELO、PEDro 和 Cochrane 对照试验中心注册库检索了截至 2018 年 6 月的随机对照试验。纳入了比较等速肌肉强化与其他康复干预或对照组治疗脑卒中后患者的随机对照试验。使用 PEDro 量表评估研究质量。计算加权均数差(WMD)和 95%置信区间(CI),并使用 I ²检验评估异质性。
结果:共纳入了 13 项(347 例患者)关于脑卒中后康复中使用等速的研究。所有试验的质量均为低到中等。等速肌肉强化可改善肌肉力量(WMD:0.8,95%CI:0.2,1.4;N=96)、活动能力(WMD:-2.03 秒,95%CI:-2.9,-1.1;N=111)和步态速度(WMD:0.9 米/秒,95%CI:0.05,1.8;N=87)。
结论:等速肌肉强化似乎是改善脑卒中患者肌肉力量、活动能力和步态的有效策略。
J Stroke Cerebrovasc Dis. 2019-9-27
J Stroke Cerebrovasc Dis. 2019-9-18
J Neurol Phys Ther. 2009-12
Front Bioeng Biotechnol. 2024-9-3